5FQL | pdb_00005fql

Insights into Hunter syndrome from the structure of iduronate-2- sulfatase

External Resource: Annotation

Domain Annotation: ECOD Classification
IMGT Antibody Annotation
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	PemK_toxin	e5fqlA1	A: alpha bundles	X: SH3	H: SH3	T: SH3	F: PemK_toxin	ECOD (develop294)

IMGT Antibody Annotation IMGT Database Homepage

Chain	Protein Name	Description	Organism Name	Gene Allele Name(s)	Domain Name(s)	Receptor Type	Receptor Description	Provenance Source
A	Iduronate-2-sulfatase	IDS	Homo sapiens (human)	IDS*01	R-LIKE-DOMAIN IDS (Pr26-550)	RPI	IDS	IMGT (202610-0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF00884	Sulfatase (Sulfatase)	Sulfatase	-	Family

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	IDURONATE-2-SULFATASE	cation binding ion binding binding calcium ion binding metal ion binding small molecule binding iduronate-2-sulfatase activity hydrolase activity, acting on ester bonds hydrolase activity catalytic activity sulfuric ester hydrolase activity	carbohydrate derivative catabolic process glycoprotein catabolic process catabolic process heparan sulfate proteoglycan metabolic process carbohydrate derivative metabolic process primary metabolic process protein catabolic process glycoprotein metabolic process macromolecule catabolic process heparan sulfate proteoglycan catabolic process metabolic process cellular process protein metabolic process macromolecule metabolic process carbohydrate derivative catabolic process glycoprotein catabolic process catabolic process heparan sulfate proteoglycan metabolic process carbohydrate derivative metabolic process primary metabolic process protein catabolic process glycoprotein metabolic process macromolecule catabolic process heparan sulfate proteoglycan catabolic process metabolic process cellular process protein metabolic process macromolecule metabolic process proteoglycan catabolic process proteoglycan metabolic process dermatan sulfate proteoglycan metabolic process dermatan sulfate proteoglycan catabolic process glycosaminoglycan metabolic process aminoglycan catabolic process glycosaminoglycan catabolic process aminoglycan metabolic process	membrane-bounded organelle intracellular anatomical structure membrane-enclosed lumen lytic vacuole vacuolar lumen vacuole intracellular membrane-bounded organelle lysosomal lumen intracellular organelle lumen intracellular organelle cellular anatomical structure organelle lumen organelle cytoplasm membrane-bounded organelle intracellular anatomical structure membrane-enclosed lumen lytic vacuole vacuolar lumen vacuole intracellular membrane-bounded organelle lysosomal lumen intracellular organelle lumen intracellular organelle cellular anatomical structure organelle lumen organelle cytoplasm lysosome

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR035874	Iduronate-2-sulfatase	Family
A	IPR024607	Sulfatase, conserved site	Conserved Site
A	IPR000917	Sulfatase, N-terminal	Domain
A	IPR017850	Alkaline-phosphatase-like, core domain superfamily	Homologous Superfamily

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: P22304	mucopolysaccharidosis type 2 mucopolysaccharidosis oligodendroglioma Pick disease primitive neuroectodermal tumor Sulfoiduronate Sulfatase Deficiency adenoma breast cancer hydrocephalus intellectual disability lung cancer malignant ependymoma mucopolysaccharidosis type 1 osteosarcoma pilocytic astrocytoma mucopolysaccharidosis type 2 mucopolysaccharidosis oligodendroglioma Pick disease primitive neuroectodermal tumor Sulfoiduronate Sulfatase Deficiency adenoma breast cancer hydrocephalus intellectual disability lung cancer malignant ependymoma mucopolysaccharidosis type 1 osteosarcoma pilocytic astrocytoma spina bifida astrocytic tumor craniosynostosis large cell medulloblastoma malignant glioma medulloblastoma ovarian cancer plasma cell myeloma subependymal giant cell astrocytoma atypical teratoid rhabdoid tumor glioblastoma inborn errors of metabolism lung benign neoplasm lysosomal storage disease malignant mesothelioma

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.